*Professor McCormick and Dr Cook reply below:
Sir, Dr Eddy's closing remarks are not unreasonable. Discussion of prevention has been muddied by the introduction of the terms primary, secondary and tertiary prevention. Secondary prevention is early treatment, tertiary prevention is rehabilitation. Both effective treatment and rehabilitation are often doctor business, but are not prevention.
The other complication is the term 'preventive medicine' itself. Narrowly defined, preventive medicine could be restricted to activities normally carried out by doctors, for example immunization, genetic counselling, or bacteriological surveillance. Broadly defined, it would include prevention of disease, injuries, and deaths by whatever means, e.g. use of condoms to prevent transmission of venereal diseases, use of goggles to prevent eye injury, or use of life-belts to prevent drowning. In speaking at the GMC conference, I was accepting the broader definition and would hold that medical students should be made aware that most cost-effective prevention strategies have little, if anything, to do with doctors. I would also wish to remind them that much of the scientific and epidemiological knowledge important for community health has been gathered by the non-medically qualified. Our success in preventing some infectious diseases has been based partially upon knowledge of cause and partially upon non-medical factors, such as social changes in living standards and hygiene. Our failure to modify death rates from cancer or cardiovascular disease is an inevitable consequence of ignorance.
J S MCCORMICK

Department of Community Health
University of Dublin Sir, 'Epidemiology' can be defined as the study of the frequency, distribution, and causation of disease in a population, taking into account factors in the physical and social environment.'. It differs from 'clinical epidemiology', therefore, which is based upon observations made in clinical (bedside) practice, in contrast to those made on population groups. 'Community control' means controlling problems affecting that group of organisms (an assemblage of people or animals occupying a given area or habitat) under consideration". Preventive (intended to prevent) is best applied to actions, and is not synonymous with prophylaxis, which relates to substances". 'Preventive medicine' is, therefore, a term currently used to embrace those actions aimed at reducing (and subsequently eliminating) disease, with the ultimate goal of a healthy community; 'disease prevention' is probably a more suitable term. In my view, Professor McCormick is correct. The vast majority of abilities (actions) required for the practice of prevention do not fall within the realm of current orthodox medical training. The correct milieu for prevention can far better be achieved by scientists, engineers, agriculturalists, nutritionists and sanitation experts with their varying fields of expertise, but with the support of politicians and govemments-". Coordination of these actions is required, however, and this necessitates a deep understanding of the epidemiology of disease (and I do not mean clinical epidemiology, which is based upon bedside observation) within the population and geographic area under consideration. Therefore, in my view, the book reviewed in your columns and to which Dr T P Eddy refers, is far too clinically orientated to have much impact upon community control or prevention of disease in the countries of Africa, Asia and elsewhere in the developing Third World. If the objective of this book was the study of the frequency, distribution and causation of disease in those countries, with the ultimate objective of community disease control, a team of non-medical personnel with special expertise in the various technical areas mentioned above, could make a far more appropriate contribution than the team of medical practitioners (most of them trained in the UK) whose training (and thinking) is not primarily directed to the basic problems underlying the disease patterns of those countries which the book's editor presumably set out to assist. But if the major objective was, in fact, primary health care, that is a very different matter.
The great strength of the undergraduate medical curriculum in the UK lies in its clinical orientation; it is difficult (and often impossible) to extrapolate this training to disease in a community setting -defined by field (not clinical) epidemiology -and certainly not that in a Third World setting. This does not mean, however, that clinical medicine is not required in the developing world. Indeed it is", and unless it is maintained and combined with primary (clinical) health care, and is carried out in equilibrium with preventive medicine, medical care as far as the individual person is concerned will topple and collapse. We require well-trained physicians and surgeons, together with those who will care for individual patients in rural areas (the balance here varies very much from country to country -what is right for Zambia for example, might be totally incorrect for Bangladesh'). But we also need those who will practice the prevention of disease and I agree with Professor McCormick who, I think, believes that it is this group which should not be dominated by orthodox-trained British-type doctors, but by specialists in the various areas mentioned above.
Thus, in summary, there are in my opinion three major issues: (1) disease prevention, which is in the main part not 'doctor business'; (2) primary health care ('rural health care'), which is basically 'doctor business' but, where adequate supervision allows, can partly be undertaken by paramedical staff; (3) clinical medicine ('tertiary care'), which is very definitely 'doctor business'. The situation in the 'developed countries' is, in fact, not so very different! G C COOK My article detailing the evidence for subacute fat embolism as the cause of multiple sclerosis! was not published as a 'hypothesis' in the Lancet and has not been 'severely criticised by neuropathologists'. Only one comment was published", It is established that fat embolism is a cause of disseminated cerebral plaques:' and it is unreasonable to suppose that it does not also affect the cord. The existence of a subacute syndrome is being increasingly recognized", I do not know of any pathologist who would support the assertion that the areas offocal demyelination and shadow plaques, seen in patients dying after a delay with acute fat embolism, are the result of Wallerian degeneration.
Emboli cause perivenous demyelination and can also account for single lesion syndromes. It is necessary to draw attention, yet again, to the nonsense of requiring evidence of more than one lesion, disseminated in time and place in the nervous system, for a 'diagnosis' and before trials of therapy are undertaken.
In relation to the recent trials, Dr Bates implies that criticism has been confined to the 'lay press', despite the publication of several detailed letters in the journals involved.
Dr Bates now feels that hyperbaric oxygen has no place in the treatment of patients with multiple sclerosis, despite positive results in both British trials. In the Newcastle trial" in which Dr Bates participated, 16 out of 60 patients improved, compared with 4 out of 57 in the control group. This is Journal of the Royal Society of Medicine Volume 80 April1987 259 highly significant (P<O.01), but the authors limited their tests of significance to individual systems, as, for exam ple, in cerebellar or pyramidal function. This can only be defended if the disabilities in the treated and control patients are carefully matched, because of the variable age of lesions. The patient reports for bowel and bladder function also indicated that there was a significant benefit from oxygen therapy, with 12 out of 51 affected patients improving, compared to 3 out of 47 in the control group. This is also highly significant (P<0.03), but was dismissed as 'subjective'. With no follow-on treatment, it is not surprising that the benefit has not been maintained.
In the more recent study by Wiles et al. 6 , the overall results are not available; only the statistical analyses have been published, but they contain levels of significance. The only numerical data given relate to 20 of the patients with the most severe disturbances of bladder function, who were selected for cystometric studies. Of the 9 patients who received oxygen, 5 showed improvement of bladder capacity and 4 remained stable. In the control group of 11 patients, only one patient improved, but one deteriorated and the remaining 9 patients did not change. The simple test of significance used, by not allowing for the patient in the control group who deteriorated, gave a P value of 0.07. Allowing for this factor, the result becomes significant (P<0.03) at the same level achieved in the Newcastle trial and the successful study by Fischer et al,' Subgroups of patients have also been shown to have benefited in other trials reported as negative. Another detailed study of bladder function using hyperbaric oxygen in multiple sclerosis patients, conducted by urologists, has also reported benefit under double-blind conditions".
As the editorial that accompanied the trial by Fischer et al. stressed, it is essential in therapeutic trials in multiple sclerosis for patients to be matched for age, sex, type of disease and clinical course. By careful attention to this detail, Fischer et al,' demonstrated a clearly beneficial effect from oxygen therapy, the overall difference between the treated and control groups being highly significant (P<O.OOOl). The study has established a benchmark for trials in this disease. In the British trials and several further American studies only the patient groups were matched, not the individual patients.
Of course the results of oxygen therapy in chronic patients, although statistically significant in several trials, are not spectacular, but can dramatic results be expected in patients with typical disease durations of 12 years and average Kurtzke scores of 15-0? Perhaps Dr Bates may care to detail the extent of the sclerosis in the nervous system in these patients and how much of the damage is likely to be reversible? To attempt to dismiss the use of oxygen in the disease process underlying multiple sclerosis, based on trials of chronic patients, is scientifically indefensible and obviously absurd.
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